🔥 Wednesday 22 October 2025 Wed, 22 Oct 2025

Torque Metals reports breakthrough drilling results at its Paris Gold Project, extending high-grade gold mineralisation beyond existing resources and maintaining strong financial footing for ongoing exploration.

Kali Metals has identified a new high-grade gold prospect at its Marble Bar Project, extending the gold strike length to 3km, while maintaining a robust cash balance of A$5.13 million following a recent capital raise.

Mont Royal Resources has finalized its merger with Commerce Resources, creating a dual-listed critical metals company focused on advancing one of North America’s largest rare earth deposits in Québec. Backed by a fresh A$10 million capital raise and a seasoned leadership team, Mont Royal is poised to become a key player in the global rare earths market.

King River Resources reports encouraging gold assay results from its Kurundi Project and promising soil geochemical anomalies at Kuiper IOCG targets, underpinning ongoing exploration momentum in the Tennant Creek region.

Great Northern Minerals has secured full ownership of the Catalyst Ridge Project in California’s Mountain Pass District, initiating exploration backed by a $2.6 million capital raise and strategic US appointments.

Kula Gold reports a maiden inferred tailings resource at Mt Palmer, confirms a significant niobium anomaly in Malawi, and completes a $2.5 million strategic placement to Forrestania Resources.

GR Engineering Services Limited reported a robust FY25 with revenue climbing to $479 million and EBITDA surging to $57.2 million, supported by successful project completions and an expanded contract pipeline. The company declared a higher fully franked dividend and maintains a strong cash position as it looks ahead to FY26.

ABx Group is set to begin drilling at its T8 Rare Earths discovery in northern Tasmania, targeting expansion of high-grade dysprosium and terbium mineralisation critical for advanced technologies.

Sigma Healthcare’s 2025 AGM reveals a robust year of transformation post-merger with Chemist Warehouse, highlighted by upgraded synergy targets and impressive financial gains.

Sigma Healthcare’s transformative merger with Chemist Warehouse has propelled the company into Australia’s top 20 ASX firms, with FY25 results exceeding expectations and synergy targets nearly doubling.

Starpharma has secured a $5.5 million upfront payment from Genentech as part of a new collaboration to develop dendrimer-drug conjugates targeting cancer therapies. The partnership includes potential milestone payments exceeding half a billion dollars and tiered royalties.

MAAS Group Holdings reported a 6% rise in FY25 underlying EBITDA to $219.4 million, driven by strong construction materials growth and strategic acquisitions. The company projects FY26 EBITDA between $240 million and $270 million, underpinned by renewable energy projects and a robust capital recycling program.

Maas Group Holdings delivered a record $219.4 million Underlying EBITDA in FY25, driven by strategic acquisitions and disciplined capital recycling. The company projects further growth with FY26 EBITDA guidance between $240 million and $270 million amid stable market conditions and expanding renewable energy projects.

Aeris Resources reported steady Q1 FY26 production with 10.3kt copper equivalent at AISC of A$4.64/lb, alongside significant growth capital investment and promising exploration results.

MedAdvisor reports a sharp 53% drop in 1Q FY26 revenue driven by U.S. regulatory and sector challenges, while advancing a major platform transformation and selling its ANZ business to emerge debt-free.

Greatland Resources has kicked off FY26 with a drilling program at Telfer that has already surpassed targets, revealing a promising new high-grade zone underground and advancing multiple resource extensions.

Resolution Minerals is fast-tracking its downstream antimony strategy in Idaho, aiming to become a key US supplier while preparing for a Nasdaq listing with Tribeca Capital's support.

Vitasora Health has received $2.43 million from a cornerstone investor, advancing its $11 million capital raise and reinforcing its path to profitability by Q4 FY2026. The company’s expanding US partnerships and technology investments signal growing market confidence.

Element 25 has appointed Altris Engineering to lead the AU$64.8 million expansion of its Butcherbird manganese mine, a move that underpins its strategy to supply high-purity battery materials to the US electric vehicle market.

Imricor Medical Systems made significant regulatory strides with FDA submissions for its MRI-guided cardiac ablation devices and launched NorthStar commercially in Europe, even as it reported increased cash outflows in Q3 CY25.

Gorilla Gold Mines Ltd has raised A$31.7 million through a placement to accelerate exploration and resource growth at its key Western Australian gold projects. The capital injection strengthens the company’s cash position to about A$42 million, supporting ongoing and planned drilling campaigns.

Apiam Animal Health Limited has entered a binding agreement with Adamantem Capital Fund II for a $228.4 million acquisition via a scheme of arrangement, offering shareholders a significant premium and flexible cash or scrip consideration options.

ACDC Metals reports compelling mineralogy results from its Goschen Central project, highlighting elevated rare earth element grades that reinforce its economic potential. The announcement coincides with strategic momentum from the Australia-US Critical Minerals Framework, positioning the project as a key player in global supply chains.

Eden Innovations reports a surge in US orders and quotations for its OptiBlend dual fuel kits, driven by growing demand from data centres. Recent sales exceed US$300k, with a robust pipeline of US$4.4 million signalling strong market momentum.